Lmr Partners LLP Argenx Se Call Options Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$434.22 - $551.9 $14.9 Million - $19 Million
34,400 Added 400.0%
43,000 $23.3 Million
Q2 2024

Aug 14, 2024
BUY
$356.01 - $451.55 $3.06 Million - $3.88 Million
8,600 New
8,600 $3.7 Million
Q4 2023

Feb 14, 2024
BUY
$338.91 - $506.01 $2.1 Million - $3.14 Million
6,200 New
6,200 $2.36 Million
Q2 2023

Aug 14, 2023
BUY
$360.14 - $422.58 $36,014 - $42,258
100 New
100 $38,000

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email